• Patient Preferences in the Choice of Disease Modifying Drugs for Multiple Sclerosis

    Nov 1, 2013, 00:00

  • The Annual Treatment and Rehabillitation Costs of Patients with Paraplegia in the Private Health Care Setting in Greece

    Nov 1, 2013, 00:00

  • Assessing the Burden of Caregiving for Patients with Lung Cancer in Europe

    Nov 1, 2013, 00:00

  • Prototype Model in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)- A Tool to Position New Treatments in the Patient Pathway?

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in Costa Rica

    Nov 1, 2013, 00:00

  • Patient Survey- Investigation on What Impacts Patient Satisfaction, Drop-Out and Compliance in Patient Diaries

    Nov 1, 2013, 00:00

  • Characterizing Disease Burden in an Ultra-Rare Disease in the United States- Transthyretin (TTR) Amyloidosis Patients Caregivers

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Combined Treatment of Metformin and Fenofibrate on Retinopathy Progression

    Nov 1, 2013, 00:00

  • Analysis of Mandibular Test Specimens Used to Evaluate Bone Fixation Systems

    Nov 1, 2013, 00:00

  • Is Drug Innovation Still Rewarded in the Top 5 European Pharmaceutial Markets?

    Nov 1, 2013, 00:00

  • Decision Making in HIRA for 5 Years of Positive List System

    Nov 1, 2013, 00:00

  • Costo E Impacto Presupuestal Del Tratamiento Del Cáncer De Púlmon De Celulas No Pequeñas Del Tipo Adenocarcinoma Con Grado Ecog 0,1,2 En Estadio Iv Con Mutación + (EGFR O ALK) Con Terapias Blanco En México

    Nov 1, 2013, 00:00

  • Abiraterone Acetate Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer Post Chemotherapy- Cost Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Characteristics of Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Inhaled Corticosteroid/Long-Acting b2-ß2-agonist (ICS/LABA) Fixed Combination Products in English Primary Care

    Nov 1, 2013, 00:00

  • EU Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement Decisions

    Nov 1, 2013, 00:00

  • First Russian Type 2 Diabetes Mellitus Simulation Model with Discrete Events Modeling. Health-Economic Analysis

    Nov 1, 2013, 00:00

  • Grade for Quality Assessment of Efficacy and Effectiveness Studies on Anti-TNFs Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Costo E Impacto Presupuestal Del Tratamiento De La Artritis Reumatoide Moderada Y Severa Considerando El Uso De Terapias Biológicas En México

    Nov 1, 2013, 00:00

  • Evaluating Overall Survival in Oncology Trials with Subsequent Therapies- A Methodological Review and Application in Non-Small Cell Lung Cancer

    Nov 1, 2013, 00:00

  • Covering the PASS- Development of Protocol Template Language (PTL) for Data Collection and Data Management (DM) in Post-Authorization Safety Studies (PASS)

    Nov 1, 2013, 00:00

  • Impact of Public Payer Concentration on Public Sector Discounts for Selected Cancer Supportive Care Products in Brazil and Mexico

    Nov 1, 2013, 00:00

  • A UK Case Study of Societal and Herd-Effect Impact of Universal Mass Influenza Vaccination in the United Kingdom

    Nov 1, 2013, 00:00

  • A Systematic Review of Economic Evidence in Hepatitis C- Methods Used in Recent Economic Evaluations

    Nov 1, 2013, 00:00

  • Qualidade De Vida Dos Pacientes Que Utilizam Medicamentos Anti-TNF Para O Tratamento De Doenças Reumáticas No Sistema Único De Saúde Em Minas Gerais, Brasil

    Nov 1, 2013, 00:00

  • Non-Homogeneous Cost-Effectiveness Modeling of a New CHG-Dressing for Preventing Catheter-Related Bloodstream Infections for Patients in Intensive Care Units

    Nov 1, 2013, 00:00

  • Antibacterial Treatment of Meticillin-Resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections- A Cost-Effectiveness Analysis in Greece

    Nov 1, 2013, 00:00

  • Health Economics Assessment of the Cnamts Sophia Diabetic Patient Support Programme- Results of the First 4 Years

    Nov 1, 2013, 00:00

  • Burden of Varicella in Latin America- A Systematic Review and Critical Analysis

    Nov 1, 2013, 00:00

  • Efectividad Y Costo-Efectividad De La Fluoración Del Agua En La Prevención De Caries Dental

    Nov 1, 2013, 00:00

  • Cancer Patients May Have a Different Point of View on Oncology Drug Coverage Decisions Than Non-Patients

    Nov 1, 2013, 00:00

  • Study of Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Symptom Assessment Differences Between Patients and Family Members

    Nov 1, 2013, 00:00

  • The Budget Impact of Introducing Bg-12 (Dimethyl Fumarate) for Treatment of Relapse-Remitting Multiple Sclerosis (RRMS) in Canada

    Nov 1, 2013, 00:00

  • The Effect of Medical Devices with Dose-Memory and Reminder Functions on Patients’ Treatment Adherence, Confidence and Disease Self-management

    Nov 1, 2013, 00:00

  • The Impact of Sacral Neuromodulation on EQ-5D Index Scores and Costs to Manage Overactive Bladder

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Direct Medical Costs Among Patients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • Costs of Formal and Informal Home Care and Quality of Life of Patients with Multiple Sclerosis in Sweden

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Progestogen Preparations for Threatened Abortion Treatment in Ukraine

    Nov 1, 2013, 00:00

  • Anticoagulation Treatment with VKA in France, Italy, Germany, Spain and United Kingdom. Results from the React AF Study

    Nov 1, 2013, 00:00

  • Analyses Adjusting for Selective Crossover Show Improved Overall Survival with Decitabine Compared with Treatment Choice in DACO-016 Phase III Trial

    Nov 1, 2013, 00:00

  • Acceptance of Surrogate Endpoints by HTA Agencies in Europe

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life in Patients Along First Year Poststroke in Spain

    Nov 1, 2013, 00:00

  • Abiraterone and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post Chemotherapy- An Indirect Comparison and Budget Impact Analysis

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Cost of Illness Study

    Nov 1, 2013, 00:00

  • Delay of Total Hip Replacement (THR) Using HA Viscosupplementation- Is Cost Effective?

    Nov 1, 2013, 00:00

  • Methodology for Establishing Internal and External Validity When Propensity Score Matching Is Used

    Nov 1, 2013, 00:00

  • Medication Adherence and Adverse Health Outcomes in Community Dwelling Older Patients

    Nov 1, 2013, 00:00

  • Costs of Management of Pregnancy in Obese Women Across Europe- The Dali Experience

    Nov 1, 2013, 00:00

  • How Much Does Benign Prostatic Hyperplasia Cost? A Budget Impact Analysis on Italian Patients Treated with 5α-Reductase Inhibitors

    Nov 1, 2013, 00:00

  • Ruling Out IBD in the United Kingdom and Brazil- Is the Usage of F-Calprotectin in Primary Care Cost-Effective?

    Nov 1, 2013, 00:00

  • Comparison of Elderly Adults by Number of Rx Medications Used- Results from the National Health and Wellness Survey Across 5EU Countries

    Nov 1, 2013, 00:00

  • StratafixTM Knotless Tissue Control Devi A Budget Impact Analysis from Italian Health Service Perspective

    Nov 1, 2013, 00:00

  • Exploring Gender Differences in Population-Based Prevalences of Cardiovascular Diseases in Chile After the Health Care Reform of 2005

    Nov 1, 2013, 00:00

  • Patient-Reported Outcome (PRO) Claims in Products Approved for Chronic Obstructive Pulmonary Diseases (COPD) in Europe and the United States

    Nov 1, 2013, 00:00

  • Modeling Medication Adherence in Comparative Effectiveness Research

    Nov 1, 2013, 00:00

  • Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with the Hepatitis C Virus in the United States

    Nov 1, 2013, 00:00

  • Determinantes De Los Costos De Accidentes De Tránsito Ocurridos En Medellín (Colombia) 2009-2010

    Nov 1, 2013, 00:00

  • Comparison of Disease Status, Treatments and Outcomes of Patients with Psoriatic Arthritis Receiving Their First Biologic in the European Union and United States

    Nov 1, 2013, 00:00

  • A Low Antiviral Treatment Rate in Chronic Heptitis C Patients in Taiwan- A Nationwide Physician-Based Survey

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Argentina

    Nov 1, 2013, 00:00

  • The Value of Pilot Testing Pro Symptom Diaries Prior to Conducting Cognitive Debriefing Interviews in Children/Adolescents- Qualitative and Quantitative Insights

    Nov 1, 2013, 00:00

  • Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)- Responder Analysis of Who Functional Class III Patients from the Patent-1 Study

    Nov 1, 2013, 00:00

  • A Systematic Comparison of Market Access and Reimbursement Pathways for Diagnostic Tests in Germany, United Kingdom and the United States

    Nov 1, 2013, 00:00

  • Analysis of Total Treatment Costs of Organophosphorous Poisoning in a Tertiary Care Hospital

    Nov 1, 2013, 00:00

  • Overcoming the HTA Hurdle in Germany- Key Considerations for a Manufacturer’s Pricing and Market Access Strategy

    Nov 1, 2013, 00:00

  • Economic Evaluation of Direct Acting Antiviral (DAA) Treatments for Hepatitis C Virus (HCV) Infection in Previously Treated Patients from the Peruvian Health Care System Perspective

    Nov 1, 2013, 00:00

  • Prevalence of Risk Factors of St Elevated Myocardial Infarction

    Nov 1, 2013, 00:00

  • Biosimilar and Originator Biologic Pricing Dynamics in Emerging Markets

    Nov 1, 2013, 00:00

  • Exploring the Key Decision Drivers Provided by HTA Agencies Rejecting Submissions with ICERs Lower Than the Threshold

    Nov 1, 2013, 00:00

  • Payer Assessment and Reimbursement Policy for Rare Diseases- A Review of the Literature

    Nov 1, 2013, 00:00

  • Classification of Cognitive Dysfunction and Cognitive Normal Using Scores from Four Cognitive Assessments in Patients with Depressive Disorder

    Nov 1, 2013, 00:00

  • Web-Based of Topic Selection for Comparative Effectiveness Research in Korea

    Nov 1, 2013, 00:00

  • Confidential Patient Access Schemes in the United Kingdom – Do They Affect Prices in Other Markets?

    Nov 1, 2013, 00:00

  • Dynamic Modeling of Vector-Borne Diseases (VBD)- The Example of Malaria

    Nov 1, 2013, 00:00

  • The Attendance of the Fourth Screening Round (2008-2009) of the Hungarian Organized, Nationwide Breast Cancer Screening Program

    Nov 1, 2013, 00:00

  • Direct and Indirect Burden Associated with Parents Whose Infant Has Been Hospitalized for a Lower Respiratory Tract Infection (LRTI) in Greece

    Nov 1, 2013, 00:00

  • Estimating Chronic Disease PREVALENCE from Claims Data- Reducing Bias by Accounting for Diseased Individuals Who Do Not Generate Claims

    Nov 1, 2013, 00:00

  • The Health of Health Technology Assessment in Ireland- Five Points for Improvement

    Nov 1, 2013, 00:00

  • Reduction in NSAIDS Consumption After Viscosupplementation with HA- Is It Costs Saving?

    Nov 1, 2013, 00:00

  • Differences in Approach to Biosimilars- Nice Versus SMC Recommendations

    Nov 1, 2013, 00:00

  • The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity Disorder

    Nov 1, 2013, 00:00

  • Screening Characteristics and Diabetes Biomarkers in French and UK Patient-Level Databases

    Nov 1, 2013, 00:00

  • Medication Use Patterns and Adherence After Initiating Antipsychotics Treatment for Patients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • Causal Analysis of Longitudinal Patient Turnover Data at Hepatitis-C

    Nov 1, 2013, 00:00

  • The Cost of Stopping (Futility) Rules Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients in Brazil

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Dl Tratamiento Profiláctico Versus a Demanda En Adultos Jóvenes Con Hemofilia a Severa En Colombia

    Nov 1, 2013, 00:00

  • A Choice of Business for the Pharmaceutical Industry “Seguro Popular” in Mexico

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Universal Paediatric Rotavirus Vaccination with RIX4414 in Greece

    Nov 1, 2013, 00:00

  • Indirect Comparison of Joint Damage Prevention with Adalimumab V. Abatacept, Each in Combination with Methotrexate, in Early Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Análisis De Minimización De Costos De Iobitridol Versus Otros Medios De Contraste Iodados Iso E Hipo-Osmolales En Población General

    Nov 1, 2013, 00:00

  • Exploring the Feasibility of the Instrument Used in Determination of Willingness-To-Pay Per Quality-Adjusted Life-Year in Malaysia

    Nov 1, 2013, 00:00

  • Results of a Study Using a Tablet PC to Collect PROs in Elderly Population

    Nov 1, 2013, 00:00

  • Patient-Level Markov Model to Assess Economic Impact of New Antipsychotics Introduction in Schizophrenia

    Nov 1, 2013, 00:00

  • Pharmaceutical Regulation in Europe and Its Impact on Corporate RD

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in Japan

    Nov 1, 2013, 00:00

  • The Determinants of Innovation – A Brief Study of Issues Influencing Innovation in the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Use of Antenatal Corticosteroids Lowers Hospitalization Costs Related to Prematurity

    Nov 1, 2013, 00:00

  • Agreement Between Child and Parent Symptom Diary Responses in Chronic Constipation (CC) and Irritable Bowel Syndrome with Constipation (IBS-C)- Implications for the Measurement of Symptoms in Young Children

    Nov 1, 2013, 00:00

  • The Burden of Resistant Hypertension in 5 European Countries

    Nov 1, 2013, 00:00

  • Feasibility of Use of Medical Transcription Data for Real World Evidence Generation in the United States- A Pilot Study of Patients with Systemic Lupus Erythematosus Initiated on Belimumab

    Nov 1, 2013, 00:00

  • Orphan Drug Access- Risk/Reward Analysis of Local Clinical Development in Chile

    Nov 1, 2013, 00:00

  • Hepatitis C Virus Infection Treatment Completion- An Analysis of the Quebec Provincial Reimbursement Program Database

    Nov 1, 2013, 00:00

  • Identification of the Treatment Pathway of Metastatic Castrate-Resistant Prostate Cancer in Scotland- A Chart Review

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of the Fixed-Dose Combination of Abacavir/Lamivudine in the Antiretroviral Therapy of Naïve HIV Infected Patients in Russia

    Nov 1, 2013, 00:00

  • Public Preference Elicitation in Drug Reimbursement Using Multi-Criteria Decision Analysis (MCDA) for Universal Health Insurance System in South Korea

    Nov 1, 2013, 00:00

  • Essential Medicine List (Cuadro Básico) in México. Is It a Guideline for Decision Making on the Current and Future Health Needs?

    Nov 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Isolated and Concomitant Aortic Valve Replacements in Germany

    Nov 1, 2013, 00:00

  • Health Outcomes at 6 to 120 Months Since Heart Transplant in Spain- Clinical Status, Health Related-Quality of Life and Utility Assessment

    Nov 1, 2013, 00:00

  • Market Access of Implantable Medical Devices- Evidentiary Requirements Across Global Markets

    Nov 1, 2013, 00:00

  • Trastuzumabe Para Câncer De Mama Com Superexpressão De HER-2- Evidência De Eficácia, Segurança E Estimativa De Custo

    Nov 1, 2013, 00:00

  • Parameter Uncertainty in Value Based Multi Criteria Decision Analysis- A Systematic Review of Methods

    Nov 1, 2013, 00:00

  • The Expected Health Economic Value of Using Circulating Tumor Cells to Personalize Cancer Treatment

    Nov 1, 2013, 00:00

  • Assessment of the Budgetary Impact of Improving the Use of Evidence-Based Medicine in the Treatment of Patients with Heart Failure and Left Ventricular Dysfunction in England

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life and Utility in Patients with Diabetic Foot Syndrome - An EQ-5D Survey in Poland

    Nov 1, 2013, 00:00

  • Long-Term Prolonged-Release Fampridine Treatment and Health-Related Quality of Life Outcomes- Interim Results of the Enable Study

    Nov 1, 2013, 00:00

  • Disponibilidad Y Fuentes De La Información Para La Toma De Decisiones En Reumatología- Uso De Los Estudios Económicos

    Nov 1, 2013, 00:00

  • The Potential Cost-Effectiveness of Obinutuzumab (Ga101) in Combination with Chlorambucil in Chronic Lymphocytic Leukemia

    Nov 1, 2013, 00:00

  • Modeling the Cardiovascular Effects of Switching Patients from Rosuvastatin to Atorvastatin

    Nov 1, 2013, 00:00

  • How Does Hospitalization Impact Insulin Treatment in Diabetes Mellitus? Results of a Retrospective German Database Analysis

    Nov 1, 2013, 00:00

  • Wellbeing, Life Satisfaction and Progression in Alzheimer’s Disease – An Alsova Follow-Up Study

    Nov 1, 2013, 00:00

  • A Review of Methods Used in Health Economic Models of Chronic Myeloid Leukemia Interventions

    Nov 1, 2013, 00:00

  • A Methodology for Predicting the Impact of Copayments on the Utilization of Health Technologies

    Nov 1, 2013, 00:00

  • Generating and Maintaining Momentum in Post-Authorisation Studies

    Nov 1, 2013, 00:00

  • The Impact of Memory Problems on Diabetes Treatment in the United Kingdom

    Nov 1, 2013, 00:00

  • Oral Hypoglycaemic Medicine (OHM) Initiation in Newly Treated Type 2 Diabetes Mellitus (T2DM) in Ireland- An Analysis of Treatment Intensification and Switching Patterns

    Nov 1, 2013, 00:00

  • Eliciting Patients’ Preferences for Epilepsy Diagnostics- A Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • Desigualdad En Salud Relativa Al Ingreso En Chile- Análisis De Descomposición Del Índice De Concentración En Hipertensión, Diabetes Y Depresión

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad Del Tratamiento Farmacológico Para Las Manifestaciones Clínicas Mucocutáneas De La Enfermedad De Behcet

    Nov 1, 2013, 00:00

  • Clinical, Epidemiological and Economic Metrics Difference Between HPV-Related and Traditional Head and Neck Cancers

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Biologic Drugs for Treatment of Poliarticular Juvenile Rheumatoid Arthritis in Russia

    Nov 1, 2013, 00:00

  • Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • Variability in Hybrid Drug Availability and Pricing in Europe

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Intravitreal Aflibercept (IVT-AFL) for Neovascular Age-Related Macular Degeneration in Spain

    Nov 1, 2013, 00:00

  • Waiting Times and Scheduling in Dermatological Practices in Germany

    Nov 1, 2013, 00:00

  • A Quebec Economic Evaluation for 36 Months of Ranibizumab for the Treatment of Diabetic Macular Edema

    Nov 1, 2013, 00:00

  • Using Lower Cost, Lower Efficacy Interventions Can Improve Population Health Outcomes Under Budget Constraints

    Nov 1, 2013, 00:00

  • Economic and Quality-Of-Life Burden of Moderate to Severe Irritable Bowel Syndrome with Constipation (IBS-C) in Spain- Interim Analysis of the IBIS-C Study

    Nov 1, 2013, 00:00

  • Assessment of Methodological Quality of Economic Evaluations in Belgian Drug Reimbursement Applications

    Nov 1, 2013, 00:00

  • Validation of the French Translated Version of the Osteoporosis Specific Morisky Medication Adherence Scale (OS-MMAS) in France

    Nov 1, 2013, 00:00

  • Differential Discouting- Capturing the Value of Living Longer and Better

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Biosimilar Infliximab Treatment for Rheumatoid Arthritis in Six Central European Countries

    Nov 1, 2013, 00:00

  • Australian Standard Costs and Consequences of Four Chemotherapy Adverse Events

    Nov 1, 2013, 00:00

  • Interim Results from the Burden of Bowel Dysfunction in Spinal Cord Injury Study

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Treatments of Type 2 Diabetes Mellitus (T2DM)- A Systematic Review (Slr)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Empiric Liposomal Amphotericin B Versus Voriconazole in Turkey

    Nov 1, 2013, 00:00

  • Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Adult Type 1 Diabetes in Kazakhstan

    Nov 1, 2013, 00:00

  • Access to Medicines Index- Measuring How Well Countries Provide Access to Medicines

    Nov 1, 2013, 00:00

  • The Development and Validation of a Quality of Life Measure for People with Mild Cognitive Impairment (The MCQ)

    Nov 1, 2013, 00:00

  • Time Dependent Resource Use and Costs Associated with Different States of Disease in Patients Diagnosed with HER-2 Positive Metastatic Breast Cancer

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom

    Nov 1, 2013, 00:00

  • The First Experiences with Reassessments and Appraisals of Conditionally Approved Expensive and Orphan Drugs in the Netherlands (2006-2013)

    Nov 1, 2013, 00:00

  • Decison Making Under Uncertainty- Coverage with Evidence Development in the Context of Medical Devices

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Sequential First- and Second-Line Treatments in Metastatic Renal Cell Carcinoma Using Real-World Data and a Patient-Level Simulation Model

    Nov 1, 2013, 00:00

  • Uncovering the Gap Between Model Validation Recommendations and Practice

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad De Everolimus Más Exemestano Para Pacientes Con Cáncer De Mama Avanzado Con Receptores Hormonales Positivos (RE+), HER2–, Que Fallaron a Los Inhibidores De Aromatasa No Esteroideos (IANES) En México

    Nov 1, 2013, 00:00

  • Efficacy of Inhaled Antibiotics in CF Patients with Chronic P. Aeruginosa Infection- A Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer

    Nov 1, 2013, 00:00

  • Factors Associated with Poor Adherence in Patients Initiating Medication for Major Depressive Disorder- Interim Results from a Prospective, Longitudinal Study

    Nov 1, 2013, 00:00

  • Glycemic, Lipid, and Blood Pressure Control Among Type 2 Diabetes Mellitus Patients in Dubai

    Nov 1, 2013, 00:00

  • Adherence to Warfarin Treatment in Brazil- Systematic Review of the Literature

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Los Profesionales De Enfermeria Con Experiencia Laboral En Uci Versus Sin Experiencia Laboral En El Error De La Medicación Parenteral En Pacientes Adultos Hospitalizados En Uci

    Nov 1, 2013, 00:00

  • Towards Evidence-Based European Policy in Clinical Trials the Survey of Attitudes Towards Trial Sites in Europe - The SAT-EU StudyTm

    Nov 1, 2013, 00:00

  • The Burden of Untreated Patients Experiencing Symptoms of Overactive Bladder

    Nov 1, 2013, 00:00

  • Review of the Use of Resource Use Instruments Based on Patient Recall in Relation to Other Methods of Cost Estimation

    Nov 1, 2013, 00:00

  • Perception of Country-Specific Health Care Reform and Consideration of Real World Evidence in Routine Practi Survey of Oncologists in European Union, United States, China and Brazil

    Nov 1, 2013, 00:00

  • Comparing the Performance of the EQ-5D-5L with the EQ-5D-3L in Stroke Patients in Japan

    Nov 1, 2013, 00:00

  • Cost Effectiveness Analysis of Boceprevir (BOC) Added to Pegifn/Ribavirin (P/R) Versus Pegifn/Ribavirin (Current Standard of Care) for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Greece

    Nov 1, 2013, 00:00

  • Burden of L-Dopa-Induced Dyskinesia in Parkinson’s Disease Patients (PD-LID) in France – the Lidia Study Economic Analysis (Levodopa Induced Dyskinesia Impact Evaluation)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of a 13-Valent Conjugate Pneumococcal Vaccination Program in COPD Patients Aged ≥50 Years in Spain- Preliminary Results

    Nov 1, 2013, 00:00

  • Comparison of Development Diagnosis Related Groups Base Rate in Hungary and Germany

    Nov 1, 2013, 00:00

  • HR-QOL Data in the Amnog Early Benefit Assessment- Industry and IQWIG/GBA Perspective

    Nov 1, 2013, 00:00

  • Threshold Selection in Biomarkers Using Cox Regression. An Application to Non-Small-Cell Lung Cancer

    Nov 1, 2013, 00:00

  • Validation of Surrogate Endpoints in Advanced Solid Tumours- Systematic Review of Statistical Methods, Results, and Implications for Policy Makers

    Nov 1, 2013, 00:00

  • Cost-Per-Responder Analysis of Biological Agents for the Treatment of Active Ankylosing Spondylitis in Germany

    Nov 1, 2013, 00:00

  • Proxy Utility Assessment in Acute Heart Failure

    Nov 1, 2013, 00:00

  • Understanding Patterns of Monitoring of Appropriate Prescribing in Europe

    Nov 1, 2013, 00:00

  • Costs of HER 2 Negative, Hormonal Receptor Positive, Metastatic Breast Cancer (MBC-HR+) Treated with Everolimus (EVE) + Exemestane (EXE) in the Brazilian Private System (BPS)- A Real World (RW) and Published Literature Analysis

    Nov 1, 2013, 00:00

  • What Clinical Benefits Could Be Expected from the Implementation of a Rotavirus Vaccination Programme in France?

    Nov 1, 2013, 00:00

  • Generic Substitution in Ireland – The Views of Key Stakeholders

    Nov 1, 2013, 00:00

  • Comparisons of the Risk for Venous Thromboembolism Between Hip and Knee Arthroplasty Using Korea National Health Insurance Claims Database

    Nov 1, 2013, 00:00

  • In-Hospital and Long-Term Mortality and Morbidity Burdens in Patients with Acute Coronary Syndromes

    Nov 1, 2013, 00:00

  • Editorial Board

    Nov 1, 2013, 00:00

  • Which Should Be the Correct NMA to Be Used? A Review of HTA Recommendations

    Nov 1, 2013, 00:00

  • Amnog Benefit Assessment- Time Delay of Market Access for Pharmaceuticals in Germany?

    Nov 1, 2013, 00:00

  • Economic Evaluation of an Urine Closed Collection System Versus a Traditional Open Device in Non-Pregnant Women

    Nov 1, 2013, 00:00

  • How Hypoglycemia Impacts Quality of Life and Treatment Satisfaction in Type 2 Diabetes Mellitus Patients on Basal-Bolus Insulin Therapy?

    Nov 1, 2013, 00:00

  • Estimación De La Prevalencia De Artritis Reumatoide En México

    Nov 1, 2013, 00:00

  • Probabilistic Sensitivity Analysis to Analyze the Cost-Effectiveness of Oral Hypoglycemic Agents in the Initial Oral Drug Treatment of Outpatients Diagnosed with Type 2 Diabetes in Primary Care

    Nov 1, 2013, 00:00

  • Argentinian Survey in Cost of Illness and Unmet Needs in Multiple Sclerosis- Treatment Experience the Costs of MS Patients in Argentina

    Nov 1, 2013, 00:00

  • Evolução Do Uso De Medicamentos Genéricos No Tratamento De Doenças Crônicas – Pbm Brasileira

    Nov 1, 2013, 00:00

  • Comparative Cost-Consequence Analysis of the Bivalent and Quadrivalent Vaccines Against HPV in Spain

    Nov 1, 2013, 00:00

  • Pricing of “Follow-On” Drugs and Competition Within Pharmaceutical Classes- Evidence from Germany 1993-2008

    Nov 1, 2013, 00:00

  • Impact of Major Clinical Events on Utilities in the Context of Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) Treated with Dialysis

    Nov 1, 2013, 00:00

  • Which Are the Attitudes of Primary Health Services Users Concerning Cost Sharing Measures in a Period of Economic Crisis in Greece?

    Nov 1, 2013, 00:00

  • Comparative Economic Analysis of Retreatment Strategies for HCV Genotype 1 Patients in Russia

    Nov 1, 2013, 00:00

  • Use of Real-World Evidence (RWE) to Validate a Trial-based Health Economic Model

    Nov 1, 2013, 00:00

  • User Preferences for Stroke Services in Wales

    Nov 1, 2013, 00:00

  • Orphan Drug Legislations- Heyday or Had Their Day?

    Nov 1, 2013, 00:00

  • Difference in Interdialytic Intervals Leading to Hospital Admission and Mortality in Hemodialysis Patients

    Nov 1, 2013, 00:00

  • Análisis Bibliométrico De La Producción Científica En Economía De La Salud En Latinoamérica

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Asenapine Versus Atypical Antipsychotics Used in Turkey in the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Las Cintas De Uretra Media Comparadas Con El Tratamiento Convencional De La Incontinencia Urinaria Femenina De Esfuerzo En Colombia

    Nov 1, 2013, 00:00

  • Croatia’s EU Accession in the Context of International Reference Pricing- What Will Be the Wider Impact for Pricing and Reimbursement?

    Nov 1, 2013, 00:00

  • Budget Impact of Dienogest in Treating Endometriosis Associated Pelvic Pain in Brazil- A Public Perspective Analysis

    Nov 1, 2013, 00:00

  • EQ-5D Utility Weights Associated with Response to Treatment with Matrix Applied Autologous Cultured Chondrocytes (MACI) Implant and Microfracture for Cartilage Defects of the Knee

    Nov 1, 2013, 00:00

  • The Minimal Important Decrease of Health Utility in Living Kidney Donors

    Nov 1, 2013, 00:00

  • The Impact of Commodities and Extra-Articular Manifestations in Rheumatoid Arthritis Patients

    Nov 1, 2013, 00:00

  • Prevalence of Comorbidities Among Chronic COPD Patients in the United States

    Nov 1, 2013, 00:00

  • Modelling the Health Technology Assessment (HTA) Process for Innovative Drug Technologies (IDTS) in the Turkish Health Care System

    Nov 1, 2013, 00:00

  • Estimation of the Cost of Complications Related to Glycated Hemoglobin in the Italian Diabetes Type 1 Population

    Nov 1, 2013, 00:00

  • Health Transformation Program Impact on Import and Local Pharmaceutical Consumption in Turkey

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Clopidogrel Versus Ticagrelor, Ambos En Combinación Con Asa, Para El Manejo Del Síndrome Coronario Agudo, Desde La Perspectiva Del Sistema De Salud Privado En México

    Nov 1, 2013, 00:00

  • Validation of Disease States in Schizophrenia- Comparison of Cluster Analysis Between the United States and European Populations

    Nov 1, 2013, 00:00

  • Predicting EQ-5D Utility Scores from SF-36 Scores in Patients with Rheumatoid Arthritis in Japan

    Nov 1, 2013, 00:00

  • Estimated Osteoporotic Population and the Related Medication Consumption in Municipality Level – Discrepancies Observed Through Data Visualization Approach

    Nov 1, 2013, 00:00

  • Impact of Cardiovascular Disease on Labour Force Participation- Bivariate Probit Analysis

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Tocilizumab in Combination with Methotrexate Versus Standard of Care for the Treatment of Rheumatoid Arthritis in Greece

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Intravitreal Aflibercept in Treating Neovascular Age-Related Macular Degeneration in Sweden

    Nov 1, 2013, 00:00

  • The Burden of Clostridium Difficile in Spain- A Retrospective Matched-Cohort Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab in Rheumatoid Arthritis, in Colombia

    Nov 1, 2013, 00:00

  • Use of the Clinical Practice Research Datalink (CPRD) to Assess ‘Real-World’ Management of Tuberous Sclerosis Complex (TSC) in the United Kingdom

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Screening Y Tratamiento De Hipoacusia Bilateral En Recién Nacidos (Rn) En Chile

    Nov 1, 2013, 00:00

  • Adrenal Insufficiency- Burden of Disease in France in 2011

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of Patient Perception of Arrhythmia Questionnaire in Poland

    Nov 1, 2013, 00:00

  • Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with Insulin

    Nov 1, 2013, 00:00

  • Adherence Rates for Intravenous Chemotherapy Regimens to Treat Colon Cancer

    Nov 1, 2013, 00:00

  • Boceprevir Use in Fran A Markov Model of Disease Progression and Cost-Effectiveness for Chronic Hepatitis C (Virus G1)

    Nov 1, 2013, 00:00

  • Variabilidade No Tratamento Do Cancer De Mama No Brasil

    Nov 1, 2013, 00:00

  • The Relationship Between Asthma-Specific Quality of Life and Measures of Asthma Control and Generic Quality of Life

    Nov 1, 2013, 00:00

  • Potentially Inappropriate Prescribing (PIP) and Its Association with Instrumental Activities of Daily Living (IADL) Impairment in Older People

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Carbapenems in Treatment Nosocomian Pneumonia in Ukraine

    Nov 1, 2013, 00:00

  • Economic Evaluation of HPV Vaccination Program in South Korea

    Nov 1, 2013, 00:00

  • Using Rasch Analysis to Co-Calibrate Scores from Outcome Measures Specific to Asthma (ALIS), Chronic Obstructive Pulmonary Disease (LCOPD) and Pulmonary Hypertension (CAMPHOR)

    Nov 1, 2013, 00:00

  • Using Structural Equation Modeling to Detect Response Shift and True Change in Health-Related Quality-Of-Life Scores of Breast Cancer Patients After Surgery

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

    Nov 1, 2013, 00:00

  • Treatment Patterns for Parkinson’s Disease- Real-World Evidence from the EU5 (France, Germany, Italy, Spain, and the United Kingdom)

    Nov 1, 2013, 00:00

  • Defining Eligible Patient Population in São Paulo State Based on Cleopatra Trial Inclusion Criteria- A Retrospective Analysis of Fundação Oncocentro (FOSP) Cancer Patient Registry (Registro Hospitalar Do Câncer – RHC)

    Nov 1, 2013, 00:00

  • Cost-effectiveness Analysis in the Treatment of Heavy Menstrual Bleeding in Spain

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom- Results from a Trial-Based Model

    Nov 1, 2013, 00:00

  • Point of Care Tests- The Long and Winding Road to Reimbursement

    Nov 1, 2013, 00:00

  • Persistence with Medications- A Discrete Choice Experiment of Preferences Among Hypertensive Patients

    Nov 1, 2013, 00:00

  • A Budget Impact and Cost-Effectiveness Analysis of Blood Glucose Monitoring System in One Italian Region

    Nov 1, 2013, 00:00

  • Health Care Cost of Controlled Versus Uncontrolled Type 2 Diabetes Patients in Greece

    Nov 1, 2013, 00:00

  • Peritonitis Fluid Treatment in Russian Federation- Evaluation of Economical Burden in Real Clinical Practice

    Nov 1, 2013, 00:00

  • Would a New Therapy for Children Be Refused in the Context of the German Amnog?

    Nov 1, 2013, 00:00

  • Barriers to Biologic Therapy Use for Autoimmune Disorders in Emerging Markets

    Nov 1, 2013, 00:00

  • Coronary Artery Disease, Diabetes, and Health-Related Quality of Life- Findings of a Cohort Study from India

    Nov 1, 2013, 00:00

  • Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Italy

    Nov 1, 2013, 00:00

  • Feasibility of Medicines Review to Reduce Potentially Inappropriate Medicines in the Elderly- The OPTI-SCRIPT Cluster Randomized Controlled Trial

    Nov 1, 2013, 00:00

  • Economical Losses Due to Disablementparents Carring for Children with Oncohematological Diseases

    Nov 1, 2013, 00:00

  • Modelling the Natural History of Schizophrenia- Comparison of Naïve Versus Advanced Statistical Methods

    Nov 1, 2013, 00:00

  • Economic Burden of Coronary Heart Disease in the Patients Attending National Heart Center, Kathmandu, Nepal

    Nov 1, 2013, 00:00

  • Epidemiology and Economic Studies on Patients Diagnosed with Insomnia- A Review of the Literature

    Nov 1, 2013, 00:00

  • A Comparison of the Relative Weights of Health Domains on Global Retrospective and Experienced Health and Well-Being

    Nov 1, 2013, 00:00

  • The Potential Impact of Amnog-Triggered International Referenc Pricing- A Scenario from DPP-IV Inhibitors

    Nov 1, 2013, 00:00

  • Caregiver Burden in Fragile X Syndrome as a Function of a Health State Utility Index in the United States

    Nov 1, 2013, 00:00

  • Effects of Excess Use of Coronary Angiography and Its Association with Mortality Rates, Health Care Costs and Hospital Quality in Turkey

    Nov 1, 2013, 00:00

  • Update of the Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID)- Inclusion of E-PRO Information

    Nov 1, 2013, 00:00

  • Bivariate Indirect Comparison Meta-Analysis Model in Economic Evaluation of Cancer Treatments

    Nov 1, 2013, 00:00

  • Children with Atopic Dermatitis- Monitoring a French Cohort Over a Nine-Year Period

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Conservative Therapy Versus Cystectomy for Non-Muscle Invasive Bladder Cancer Patients

    Nov 1, 2013, 00:00

  • Divergence of HTA Decisions Across Countries- Case Analysis of Ivabradine

    Nov 1, 2013, 00:00

  • Cell Therapies- Assessing the Patient Access Opportunities and Challenges That Lie Ahead

    Nov 1, 2013, 00:00

  • Market Access of Cancer Drugs in European Countries- A Matter of Setting Priorities for Resource Allocation

    Nov 1, 2013, 00:00

  • Audit of the Coverage Decision-Making Process in a Government Agency in Uruguay- From the Guidelines Till the Patients

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Apixaban for the Prevention of Venous Thrombo-Embolism in Patients Undergoing Orthopedic Replacement Surgery in Italy

    Nov 1, 2013, 00:00

  • Integrating the Long-Term Health Burden of Oral Corticosteroids in the Cost-Effectiveness of Omalizumab

    Nov 1, 2013, 00:00

  • The Impact of the Economic Recession and Pharmaceutical-Health Service Agreement on the Probability and Time of Reimbursement of New Medicines in Ireland

    Nov 1, 2013, 00:00

  • An Analysis of Priscription and Reimbursement of Potentially Inappropriate Medication (PIM) in a German Practice Network

    Nov 1, 2013, 00:00

  • Clinical Outcomes and Health Care Costs Evaluation of Sulfonamides and Thiazolidinediones Compared with Dipeptidyl Peptidase 4 Inhibitors for the Treatment of Uncontrolled Diabetes

    Nov 1, 2013, 00:00

  • Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies from 2000 to 2012 in Turkey

    Nov 1, 2013, 00:00

  • Economic Evaluation of the Impact of New Treatment Alternatives on Market Dynamics in Respiratory Diseases; A Case Study in Turkish Health Care System

    Nov 1, 2013, 00:00

  • A Cost–Effectiveness And Budget Impact Analysis of Different Biologic Treatments for Psoriasis in Colombia

    Nov 1, 2013, 00:00

  • Estimating the Health Outcome of Treating Type 2 Diabetic Population to Target in Local Municipality Level

    Nov 1, 2013, 00:00

  • Economic Evaluation of Intravenous Iodinated Contrast Media in Italy

    Nov 1, 2013, 00:00

  • Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease in India

    Nov 1, 2013, 00:00

  • Are Generic Drugs Defined and Classified Consistently Around the World?

    Nov 1, 2013, 00:00

  • The Patient-Reported Outcomes Measurement Information System in Spanish

    Nov 1, 2013, 00:00

  • The Affordability of Oncology and HIV/AIDS Technologies in Brazil Compared to the United States and Other OECD Countries

    Nov 1, 2013, 00:00

  • Health-Economic Assessment of the Use of Catheter-Based Renal Denervation in Patients with Resistant Hypertension in Mexico

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Apixaban Versus Standard of Care for the Prevention of Stroke- An Analysis of Patients with Atrial Fibrillation in Greece

    Nov 1, 2013, 00:00

  • Associations Between Overall Care Experience Ratings and Utility and Psychological Well-Being in Men Recently Diagnosed with Prostate Cancer- Findings from a Population-Based Study

    Nov 1, 2013, 00:00

  • Patient-Reported Outcome Measures for Systemic Lupus Erythematosus Clinical Trials- A Content Validity and Psychometric Performance Review

    Nov 1, 2013, 00:00

  • Real World Management and Costs in Unresectable Metastatic Melanoma (MM) Patients- Update of a Pilot Study Based on an Institutional Patient Registry

    Nov 1, 2013, 00:00

  • Affordability of Antihypertensive Treatment in Mexico

    Nov 1, 2013, 00:00

  • Analysis of Transparency Amongst International Health Technology Assessment Organizations

    Nov 1, 2013, 00:00

  • Faulty Connections- Can Criticisms of Network Meta-Analysis in Nice Submissions Be Avoided?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of the Systematic Identification and Treatment of Comorbid Major Depression for People with Chronic Diseases- The Example of Cancer

    Nov 1, 2013, 00:00

  • Treatment Satisfaction in Patients with Atrial Fibrillation on New Oral Anticoagulants as Measured with Pact-Q2- Prefer in AF Registry

    Nov 1, 2013, 00:00

  • Obesity Trends 2006-2012 in the United States- Results from the National Health and Wellness Survey

    Nov 1, 2013, 00:00

  • The Use of Oral Anticoagulation Drugs for Stroke Prevention in Nonvalvular Atrial Fibrilation in France, Italy, Germany, Spain and the United Kingdom- Is Current Practice Consistent with the 2012 ESC Recommendations?

    Nov 1, 2013, 00:00

  • Determinants of Non-Adherence to Medications Among Chronic Patients in Maccabi Health Care Services

    Nov 1, 2013, 00:00

  • Resultados De La Encuesta “Change Pain” Latinoamericana- Diagnostico Y Tratamiento Actual De Los Pacientes Con Dolor Crónico

    Nov 1, 2013, 00:00

  • A Nationwide Survey on Patient Safety Culture in Japan

    Nov 1, 2013, 00:00

  • Analyzing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Rheumatoid Arthritis from a Public Perspective in Brazil

    Nov 1, 2013, 00:00

  • Evaluating the Burden of Bone Metastases (BM) on Patients with Castration-Resistant Prostate Cancer (CRPC) and Their Treating Physicians- Findings from a Routine Practice Study in 13 Medium-Sized European Countries

    Nov 1, 2013, 00:00

  • Early Response to Certolizumab Pegol in Rheumatoid Arthritis Predicts Outcome at One Year

    Nov 1, 2013, 00:00

  • One Line Does Not Make a Picture- Real-World Cost-Effectiveness of Multiple Myeloma Treatments Using a Full Disease Model

    Nov 1, 2013, 00:00

  • From “Generic Scheme” to “Brand-Generic Scheme”- The Effect of New Policy (2003-2004) on Efficiency of Iranian Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Effect of Nurse-Led Medication Reviews in Psychiatric Patients – An Interventional Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Capsule Endoscopy (Pillcam®) in the Diagnosis of Small Bowel Crohn’s Disease

    Nov 1, 2013, 00:00

  • Health Technology Assessment Report for Positron Emission Tomography in Patients with Cancer

    Nov 1, 2013, 00:00

  • Treatment Patterns and Costs Associated with Chronic Lymphocytic Leukemia Chemotherapy Under the Brazilian Private Health Care Perspective- A Retrospective Analysis of the Orizon Database

    Nov 1, 2013, 00:00

  • Reaching the Middle of the Pyramid- Implications for the PMA of Pharmaceutical Drugs with the Expanding Middle Class in Brasil, Chile and Colombia

    Nov 1, 2013, 00:00

  • Clinical Practice Guideline Major Depressive Disorder for General Practitioners

    Nov 1, 2013, 00:00

  • Estimating the Budget Implications of Radium Ra 223 Dichloride in Castration-Resistant Prostate Cancer Patients with Non-Visceral Bone Metastases Treated in Infusion Centers in the United States

    Nov 1, 2013, 00:00

  • Utilizing Storytelling to Promote Rational Antibiotic Use in 9-11 Years Old School Children in Iran

    Nov 1, 2013, 00:00

  • Comparative Efficacy of Blood Pressure Lowering Drugs in Primary Prevention for Elderly Patients

    Nov 1, 2013, 00:00

  • Follow-On Health Care Costs in Patients with Acute Coronary Syndrome (ACS)

    Nov 1, 2013, 00:00

  • How the Pricing Strategy of 2nd Generation HCV Direct Antiviral Agents Can Affect the Number of Treated Patients in Italy and the National Drug Budget

    Nov 1, 2013, 00:00

  • Pharmacotherapeutic Monitoring of Patients Using Immunobiological in a Health Insurance Company in Brazil- To Know to Better Manage

    Nov 1, 2013, 00:00

  • Patient-Centered Outcomes in Upper Limb Spasticity- Results from a Large International Cohort Study (ULIS-2)

    Nov 1, 2013, 00:00

  • Risk of Psychiatric and Neurological Diseases in Patients with Workspace Mobbing Experience in Germany- A Retrospective Database Analysis

    Nov 1, 2013, 00:00

  • Enteral Diets (ED)- A Cost-Comparison Analysis for In-Hospital Preparations Based on Real World Observation

    Nov 1, 2013, 00:00

  • Empirical Evidence for the Validity and Reliability of Resource-Use Measures Based on Patient Recall- A Systematic Review

    Nov 1, 2013, 00:00

  • Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis- The Role of the Patient-Reported Outcome Consortium’s RA Working Group

    Nov 1, 2013, 00:00

  • Cost and Cost-Effectiveness Analyses for Moderate and Severe COPD Patients Treated Uniquely with Tiotropium 18 Mcg Od for Twenty-Four Months

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Colombia

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Ioversol Versus Iohexol for Diagnostic Procedures

    Nov 1, 2013, 00:00

  • Costo-Utilidad De Intervenciones Preventivas Contra El Cáncer De Cuello Uterino En Mujeres Peruanas

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Pharmacogenetic Screening Prior to Initiation of Carbamazepine Treatment for Epilepsy

    Nov 1, 2013, 00:00

  • The Relative Efficacy and Safety of Simeprevir and Telaprevir in Treatment-Naïve Hepatitis C Infected Patients in a Japanese Population – A Bayesian Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France

    Nov 1, 2013, 00:00

  • Variation in Treatment Patterns and Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Across European Countries

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Prepex Device and Dorsal–Slit Technique for Scaling-Up Adult Safe Medical Male Circumcision in HIV Prevention in Rural Central Uganda

    Nov 1, 2013, 00:00

  • Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Sitagliptin (SITA) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

    Nov 1, 2013, 00:00

  • Revisión De Estudios Del Coste De La Enfermedad

    Nov 1, 2013, 00:00

  • Are ICER Threshold Values Malleable? The Case of Life-Extending Cancer Treatments at the End of Life

    Nov 1, 2013, 00:00

  • An Economic Evaluation Alongside a Clinical Trial (EEACT) in Pelvic Floor Medicine

    Nov 1, 2013, 00:00

  • Added Value and Future Adoption of a New Medical Imaging Technology for Interventional Cardiology

    Nov 1, 2013, 00:00

  • The Future of Individual Funding Requests in Clinical Commissioning Groups Era

    Nov 1, 2013, 00:00

  • The Effect of Positive Margins on Outcomes in Breast Cancer

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Different Antiviral Therapies in the Treatment of Russian Patients with Chronic Hepatitis C

    Nov 1, 2013, 00:00

  • Mixed Treatment Comparison of Adverse Events for BG-12, Glatiramer, and Teriflunomide for the Treatment of Relapsing Forms of Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Loss of Productivity in Polish Patients with Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Remote Patient Monitoring in CRT-D Recipients May Reduce Use of Hospital-Based Care

    Nov 1, 2013, 00:00

  • Preliminary Results Quality of Life, Physical Activity, and Sedentary Behavior in College Students

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Apixaban Versus Dabigatran for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain

    Nov 1, 2013, 00:00

  • Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population

    Nov 1, 2013, 00:00

  • Diagnosis of Pancreatic Exocrine Insufficiency in Chronic Pancreatitis, Pancreatic Cancer and Gastrointestinal or Pancreatic Surgery Patients- A Systematic Literature Review and Expert Consensus on the Accuracy of Diagnostic Test Used in Sp ...

    Nov 1, 2013, 00:00

  • Advanced Budget Notification (ABN)- Is There a Win-Win for Manufacturers and Payers Given the Current Austerity Measures Across the EU

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Adherence to Antiretroviral Treatment (ART) by HIV Patients- An Analysis with the Quebec (Canada) Public Drug Plan Database

    Nov 1, 2013, 00:00

  • EVPI Curves in Practice

    Nov 1, 2013, 00:00

  • Budget Impact Analisis of Switching from DPT and Monovalent Vaccines to DTaP–IPV-Hib Combined Vaccine into Russian Immunization Schedule

    Nov 1, 2013, 00:00

  • Costs Evaluations of Ready-To-Use Propofol Syringes Versus Syringes Drawn from Vials in Critically Ill

    Nov 1, 2013, 00:00

  • The Financial Impact of Increasing Home-Based High Dose Haemodialysis and Peritoneal Dialysis

    Nov 1, 2013, 00:00

  • Price Differences Triggered by the Availability of Biosimilars in Developed Countries

    Nov 1, 2013, 00:00

  • Technical Errors in Cost-Effectiveness Models- Evidence from the Single Technology Appraisal Programme in England and Wales

    Nov 1, 2013, 00:00

  • The Relationship Between Submitted Line of Therapy and Reimbursement Decisions in Solid State Tumor Cancer Drugs

    Nov 1, 2013, 00:00

  • Budget Impact and Thresholds- How Are Real Decisions Made? - Expected Utility or Prospect Theory?

    Nov 1, 2013, 00:00

  • Treatment Patterns and Burden of Illness of Acromegaly in the United Kingdom- Real World (RW) Data from Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • Ações De Farmacovigilância- Relato De Notificações De Medicamentos À Agência Nacional De Vigilância Sanitária (ANVISA) – Brasil

    Nov 1, 2013, 00:00

  • Real Life Applications of Social Security Institution (SSI) Regulations; A Case Study of DPP4 Inhibitors in Treatment of Diabetes in Turkish Health Care System

    Nov 1, 2013, 00:00

  • Estimating the Impact of Endogenous Substance Abuse on Self-Reported Health Status

    Nov 1, 2013, 00:00

  • Argentina’s Generic Drug Law- Was It Successful?

    Nov 1, 2013, 00:00

  • Understanding the Effect of Clostridium Difficile Infection on Hospital Mortality in England, the Netherlands, and Spain

    Nov 1, 2013, 00:00

  • The Budget Impact Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions in Children and Adolescents (Age ≤18 Years)

    Nov 1, 2013, 00:00

  • Utilisation and Costs of Inpatient and Outpatient Services Among Patients with Irritable Bowel Syndrome- A Study Using the Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • Challenges of Conducting Economic Evaluations Using Linked Electronic Health Records - CPRD and HES in the United Kingdom

    Nov 1, 2013, 00:00

  • Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries- THE Results of the Literature Review

    Nov 1, 2013, 00:00

  • The Burden of Illness of Pulmonary Arterial Hypertension- A Managed Care Perspective in the United States

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine for Patients with Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

    Nov 1, 2013, 00:00

  • Experiencia Inicial Con Un Nuevo Tipo De Documento De Evaluación De Tecnología Sanitaria- “Informes De Mesa De Ayuda”

    Nov 1, 2013, 00:00

  • Design of a Randomized Controlled Trial (RCT) Evaluating Outcome and Cost-Effectiveness of a Local Case Management Intervention of Patients Suffering from Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2013, 00:00

  • Pulse Pressure and Stroke Risk- Development and Validation of a Stroke Risk Equation

    Nov 1, 2013, 00:00

  • Responder Analysis of Functional Health and Well-Being in MDD- A Pooled Analysis of SF-36 Results from Three Phase III Trials with Levomilnacipran SR

    Nov 1, 2013, 00:00

  • Ánalise De Significância Do Banco De Dados De Hospitais Particulares Brasileiro

    Nov 1, 2013, 00:00

  • Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece

    Nov 1, 2013, 00:00

  • Long-Term Costs and Survival Associated with Immunosuppressant Following Liver Transplantation- A Markov Model

    Nov 1, 2013, 00:00

  • Estimates of Price and Income Elasticity in Gree Greek Debt Crisis Transforming Cigarettes into a Luxury Good

    Nov 1, 2013, 00:00

  • Evaluating Economic Burden of Tick-Borne Encephalitis. Evidence from Russia

    Nov 1, 2013, 00:00

  • Drivers of Clinician Prescribing Decisions and the Economics of Information

    Nov 1, 2013, 00:00

  • Evaluación Económica Del Uso De Dos Tratamientos Farmacológicos En Degeneración Macular Relacionada Con La Edad De Tipo Exudativa (Dmre) Para Venezuela

    Nov 1, 2013, 00:00

  • Association Between Cognitive Function and 3 Month Health Care Costs Among Patients Initiating an Antidepressant for Depressive Disorder in an Ambulatory Care Setting

    Nov 1, 2013, 00:00

  • Integración De Un Marco Conceptual Para La Evaluación De La Calidad De Servicios Farmacéuticos Hospitalarios Enfocados a La Mejora De La Farmacoterapia

    Nov 1, 2013, 00:00

  • Tobramycin Powder for Inhalation for the Treatment of Cystic Fibrosis- Analysis of the RAMQ Data

    Nov 1, 2013, 00:00

  • The Rand Negative Impact of Asthma on Quality of Life Item Bank and Short-Forms

    Nov 1, 2013, 00:00

  • Patient Survey Data Results- Preferences for Reminders in Pro Studies

    Nov 1, 2013, 00:00

  • ISPOR 4th Latin America Conference Disclosure Information

    Nov 1, 2013, 00:00

  • Direct Cost of Diabetes Mellitus and Its Complications in Spain. Seccaid Study- Spain Estimated Cost Ciberdem-Cabimer in Diabetes

    Nov 1, 2013, 00:00

  • Evaluating the Efficacy of Biosimilar Infliximab with the ACR50 Response in Patients with Rheumatoid Arthritis; A Meta-Analysis in Bayesian Framework

    Nov 1, 2013, 00:00

  • Crohn’s Disease- An Economic Assessment of Biological Drugs in Italy

    Nov 1, 2013, 00:00

  • Development of the Scharr HUD (Health Utilities Database)

    Nov 1, 2013, 00:00

  • Examining the Effects of a Functional Restoration and Pain Management Program Among Chronic Pain Patients in the Texas Workers Compensation System- Pilot Study – Part I

    Nov 1, 2013, 00:00

  • A Comparative Study on the Cost of Antibiotics for the Years 2011-2012 in Three General Hospitals of Greece

    Nov 1, 2013, 00:00

  • Dynamic Modeling to Estimate the Economic Impact of Increasing Influenza Vaccination in the United States

    Nov 1, 2013, 00:00

  • Are Monoclonal Antibodies Still Considered as Innovative by the French Health Care System? A Retrospective Analysis 2000-2012

    Nov 1, 2013, 00:00

  • Patients with Chronic Hepatitis C Virus Treated with Simeprevir Added to Peginterferon and Ribavirin Experienced Less Time with Fatigue, Depressive Symptoms, and Functional Limitations- Results from Patients in the Quest-1, Quest-2, and Pro ...

    Nov 1, 2013, 00:00

  • Modelling the Cost-Effectiveness of First Line Biologics for Rheumatoid Arthritis in Ireland

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Maternal Toxoplasma Screening in Austria- A Decision-analytic Model

    Nov 1, 2013, 00:00

  • High Dosages of Statins in High Cardiovascular Risk Patients in a Real World Setting- Treatment Patterns and Outcomes

    Nov 1, 2013, 00:00

  • Patients’ and Caregivers’ Preferences for Bone Metastases (BM) Treatments in the United States

    Nov 1, 2013, 00:00

  • Points to Consider in Multiregional Trials Using PHQ-9- A Meta-Analysis on PHQ-9

    Nov 1, 2013, 00:00

  • Serious Adverse Events for Biologic Response Modifiers Indicated for the Prophylaxis Against Transplant Rejection. an Insight from Spontaneous Adverse Event Reporting System

    Nov 1, 2013, 00:00

  • Minimal Important Difference (MID) of Response to the Hepatitis-C Virus Patient Reported Outcomes (HCV-PRO) Instrument in a Trial of Pegylated Interferon/Ribavirin (pegIFN/RBV) and Direct-Acting-Antivirals (DAA)

    Nov 1, 2013, 00:00

  • Disease Becomes Social. Health Research Conducted On, or Using, Web 2.0 Media- A Systematic Review

    Nov 1, 2013, 00:00

  • The Burden of Illness of Chronic Thromboembolic Pulmonary Hypertension- A Managed Care Perspective in the United States

    Nov 1, 2013, 00:00

  • Barriers of Access to Elective Orthopedic Procedures in Rio De Janeiro, Brazil

    Nov 1, 2013, 00:00

  • Health Economic Evidence for Medical Nutritions- Are These Interventions Value for Money?

    Nov 1, 2013, 00:00

  • Costs in Patients Along First Year Poststroke in Spain

    Nov 1, 2013, 00:00

  • A Relationship Between Body Mass Index and Health-Related Quality of Life Among Koreans with Diabetes- The Korea National Health and Nutrition Examination Survey

    Nov 1, 2013, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116 (current)
  • 117
  • 118
  • 119
  • 120
  • »